Z-2673-2014 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-2673-2014 was initiated by Becton Dickinson & Company on Jul 22, 2014 and is designated Class II. Reason for recall: BD received some reports of open seals found on the BD Posiflush SF Flush Syringe 10 mL (Ref #306553). The recall status is terminated (terminated Apr 21, 2015). Affected quantity: 3,088,320 units.

Recall details

Product Type
Devices
Report Date
Oct 1, 2014
Initiation Date
Jul 22, 2014
Termination Date
Apr 21, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,088,320 units

Product description

BD PosiFlush SF Saline Flush Syringe 0.9 Sodium Chloride Injection, USP 10 mL REF 306553. Intended to be used only for the flushing of indwelling vascular access devices.10 mL BD PosiFlush Normal Saline Flush Syringes are generally compatible for use with syringe pumps.

Reason for recall

BD received some reports of open seals found on the BD Posiflush SF Flush Syringe 10 mL (Ref #306553).

Distribution pattern

Nationwide Distribution.

Code information

REF #306553 Lot numbers 3024261 - exp 12-2015 3046276 - exp 01-2016 4128353 - exp 04-2017

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2673-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2673-2014. Report a data issue: hello@regdatalab.com.